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Background: Birth weight and adult body weight have independently been associated with 
breast cancer risk. Thus, we hypothesize that low birth weight, in combination with adult 
overweight, may influence premenopausal hormonal levels over an entire menstrual cycle. 
Methods: Among 204 healthy women, aged 25–35 years, who participated in the Norwegian 
EBBA-I Study, birth weight and age at menarche, were assessed. Levels of 17 -estradiol 
were measured in daily saliva samples over one menstrual cycle using radioimmunoassay 
(RIA). Measurements of body composition; waist circumference (cm), body mass index 
(BMI, kg/m
2) and total fat percentage (DEXA, %) were assessed. Fasting blood samples were 
drawn, and serum concentrations of lipids and hormones determined.  
Results: The participating women had mean birth weight of 3389 g and age at menarche 13.1 
years. Women within the highest tertile of birth weight had the lowest 17 -estradiol 
throughout the menstrual cycle (p=0.03), and they tended to have a later age at menarche (p= 
0.06). When we looked into birth weight in combination with adult attained weight, we found 
that women with lower birth weights, combined with excess weight during adulthood, had 
higher levels of free 17 -estradiol over an entire menstrual cycle compared with women with 
high birth weights and adult overweight. Women with birth weights < 3530 g, who later 
developed excess body weight (waist   84 cm), showed 33% higher 17 -estradiol 
concentrations over a menstrual cycle compared with women with higher birth weights 
(  3530 g) and adult excess body weight (p = 0.03). The association was even more 
pronounced in women with birth weights < 3220 g, early age at menarche (< 12 years) and 
adult overweight.  
Conclusion: Our findings support variation of premenopausal levels of 17 -estradiol in 
response to birth weight and energy status in adult life, suggesting that women with low birth 
weight in combination with adult overweight are put at risk for higher estradiol levels 
throughout menstrual cycles, of possible importance for breast cancer risk. 
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Introduction 
Several studies have observed a strong relationship between birth weight and later risk of 
chronic diseases, indicating that fetal conditions may influence later susceptibility to adult 
disease (‘Forsdahl- Barker hypothesis’) (1), (2), (3). Thus, women with low birth weight may 
have different set points for their physiological ovarian responsiveness to changes in energy 
balance later in life compared with women with higher birth weight.  
Furthermore, the westernization of society including high levels of available energy 
combined with low overall energy expenditure, could provide new challenges for normal 
physiology and response, not only during the fetal period and early childhood, but also 
throughout life. It has been observed that birth size, a marker of fetal growth and intrauterine 
environment (4), together with later growth pattern and availability of energy, may influence 
later risk of chronic diseases, as for example diabetes or breast cancer (5), (6), (7), (8). 
However, the pattern observed is complex. Obesity during adolescence and early adult life 
has been observed to reduce premenopausal breast cancer risk, whereas later adult obesity, 
weight gain and unfavourable metabolic profiles have been observed to increase 
postmenopausal breast cancer risk (9).  
In addition, indicators of affluent and excessive energy early in life –  increased body 
weight during adolescence and a shift towards lower age at menarche (10), (11), (12), (13) – 
may interact with later energy availability and body composition, thereby affecting levels of 
endogenous hormones. Along with the downward shift in age at menarche, increases in both 
body weight and waist circumference have been observed (14), (9). Age at menarche tends to 
occur earlier, especially in those with decreasing birth weight who gain more weight during 
pre-pubertal years (5), (13), (15). Interestingly, we recently observed that women who 
experienced early age at menarche ( 12 years) and had a large waist to hip ratio, had 24% 
higher levels of estradiol over the menstrual cycle (16).  
To our knowledge, little is known about the associations of variation in birth weight, 
adult attained body composition and premenopausal levels of 17 -estradiol over an entire 
menstrual cycle. In addition, the large variation in breast cancer incidence and levels of sex 
hormones across populations has been discussed and reflects both genetic variation (17), (18) 
and variation in availability of energy factors (19). 
As steroid levels in saliva
 represent free steroid levels, rather than levels of both free 
and protein-bound circulating steroid, they allow for fine discrimination of functional
 
differences in steroid signalling. Furthermore, as saliva can be readily
 collected from  21.01.2009   3 
individuals on many occasions, it is possible
 to compare steroid levels across entire menstrual 
cycles among
 different women, rather than relying on one or a few timed blood
 samples (20).  
Thus, the aim of the present study was to test whether levels of free 17 -estradiol over 
an entire menstrual cycle were associated with birth weight in combination with attained adult 
body composition. Such an interactive effect could be important for susceptibility to breast 
cancer.  
 
Materials and Methods 
Participants and study design 
Women aged 25–35 years, living in Tromsø and surroundings during 2000-2002, were invited 
to participate in the Norwegian EBBA-I study by announcements both in newspapers and 
locally. Study participants had to meet the following criteria: self-reported regular 
menstruation (normal cycle length of 22–38 days within the previous 3 months), not taking 
hormonal contraceptives, no pregnancy or lactation over the previous 6 months, and no 
history of endocrinological (e.g. diabetes, hypo-/hyperthyroidism), gynecological or chronic 
disorders. A total of 204 women who met the inclusion criteria were subsequently enrolled 
into the study and came to the Department of Clinical Research, University Hospital of North 
Norway (UNN), at a scheduled time (21).  
 
Questionnaires 
We used a general questionnaire (self-administered and by interview) to collect information 
on ethnicity, education, menstruation and reproductive history, previous use of hormonal 
contraceptives, family history of cancer, lifetime total physical activity, smoking [‘current 
smoker’ (yes/no), ‘how many cigarettes per day’] and alcohol [ ‘do you drink alcohol’ 
(yes/no), ‘units of alcohol’]. Trained personnel conducted interviews using recall and 
memory-probing aids, including a lifetime calendar. A pre-coded food diary with a 
photographic booklet on portion size was developed and used in order to collect 7 days of 
dietary data (days 3–6 and days 21–23 of the menstrual cycle, where day 1 represented the 
onset of menstrual bleeding) (22). Average daily intake of energy and nutrients were 
computed by using a food database and software system developed at the Institute for 
Nutrition Research, University of Oslo, Norway (23). 
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Birth size, age at menarche and body composition measurements  
We collected data on birth size from personal health records. Age at menarche was assessed 
by both questionnaire and interview using the same trained nurse during the whole study 
period.  
Study participants made three subsequent visits to the study laboratory over the course 
of one menstrual period: visit 1 (days 1–4), visit 2 (midcycle) and visit 3 (days 22–25). They 
came in on the first possible day after onset of menstrual bleeding for clinical examinations, 
anthropometric measurements and provision of a fasting blood sample. All clinical procedures 
were conducted by trained nurses at the Department of Clinical Research, UNN, Tromsø. 
Anthropometric measures were taken with participants wearing lightweight clothing and no 
footwear: height and waist circumference were measured to the nearest half centimeter and 
weight to the nearest 0.1 kg on an electronic scale. Body Mass Index (kg/m
2) was used to 
estimate relative weight. Waist circumference (cm) was measured in a horizontal line 2.5 cm 
above the umbilicus. 
The participants underwent a whole body scan using Dual Energy X-ray 
Absorptiometry or DEXA (DPX-L 2288, Lunar Radiation Corporation, Madison, WI, USA) 
during midcycle (days 7-12). The same trained nurse carried out the scans, and the percentage 
of fat tissue was estimated using Lunar software.  
 
Serum samples  
Fasting serum blood samples were drawn from an antecubital vein in the morning at all three 
visits. Serum concentrations of glucose and estradiol were measured in fresh sera at the 
Department of Clinical Chemistry, UNN, Tromsø. Serum concentrations of insulin and leptin 
were measured at the Hormone Laboratory, Aker University Hospital, Oslo, in serum that was 
stored at  70˚C for up to 3 years until analysis. Serum insulin and leptin were measured by 
RIA using kits from Linco Research Inc (St Charles, MO, USA) (21). 
 
Estradiol indices and assay procedure 
From the first day of bleeding and each day during the menstrual cycle, participants collected 
saliva samples at home, in the morning, according to collection protocols previously 
established at the Reproductive Ecology Laboratory at Harvard University, USA (24). Levels 
of 17 -estradiol were measured in daily saliva samples from 20 days (reverse cycle day  5 to 
 24) of the cycle using an 
125I-labelled RIA kit (#39100, Diagnostic Systems Laboratory, 
Webster, TX, USA), along with published modifications of the manufacturer’s protocol (21).  21.01.2009   5 
All samples were run in duplicate. All of a participant’s samples were run in the same batch, 
with women randomly assigned to batches. Coefficients of variation were calculated based on 
high and low value pools (appropriate to the range of each steroid) included in each assay 
(21). 
The sensitivity of the estradiol assay (the lowest concentration of estradiol 
distinguishable from 0 at the 95% level) was 4 pmol/L. Average intra-assay variability 
(estimated from the 50% binding point of the standard curve) was 9%, and the interassay 
variability ranged from 23% for low values (15 pmol/L) to 13% for high values (50 pmol/L). 
Before statistical analysis, all cycles were aligned to the day of ovulation following published 
methods (21), based on the identification of the estradiol drop at the midcycle (day 0), which 
provides a reasonable estimate of the day of ovulation. The estradiol values for 20 
consecutive days from each cycle, aligned on day 0, were used in data analyses (day  10 to 
+9). Satisfactory identification of the midcycle estradiol drop could not be made for 14 
women and so their cycles were not aligned. However, in order to study the total variation in 
estradiol concentration throughout an entire menstrual cycle and as anovulatory cycles are 
associated with low estradiol exposure, all cycles; both anovulatory and ovulatory cycles, 
were included in this study. 
 
Statistical analysis 
The associations between birth weight, adult attained body composition and 17 -estradiol 
levels throughout a menstrual cycle were studied using linear regression analysis and linear 
mixed models for repeated measures (SAS statistical package version 9.1).  
To study in detail the association between birth weight and 17 -estradiol levels, the 
study population was divided into birth weight tertiles: < 3220 g,   3220 to 3530 g and 
  3530 g. These groups of women with different birth weights were then compared with 
regard to selected characteristics. We used one-way analysis of variance for continuous 
variables and  
2 tests for categorical variables to test for differences in means and frequencies 
of selected characteristics across tertiles of birth weight. 
 Linear regression models were used to study the associations of average salivary 17 -
estradiol concentration, birth weight, and measures of adult attained body composition, serum 
insulin and leptin. Potential confounding factors were tested and adjusted for when 
appropriate. Based on biological plausibility, covariates such as age, smoking, physical 
activity, age at menarche, energy intake, alcohol, previous use of hormonal contraceptives,  21.01.2009   6 
age at first birth and number of children were tested in the models. Age, smoking, physical 
activity and age at menarche were included in the final models due to proper model-data fit.  
We evaluated possible interactions between measures of attained adult body 
composition and serum insulin and leptin and birth weight (tertiles) by including 
multiplicative interaction tests in the models.   
To study whether variation in adult excess body weight and fat distribution modified 
the association between birth weight and salivary concentrations of 17 -estradiol, waist 
circumference were dichotomized at the 75th percentile (  84 cm). We used linear mixed 
models for repeated measures to study variations in salivary 17 -estradiol concentrations over 
the entire menstrual cycle across different subgroups of women defined by birth weight 
(tertiles) and adult body composition (75th percentile); age was included in the models. As 
the multivariate analyses only gave minor changes of our age-adjusted estimates, both in 
relation to linear regression models and in relation to linear mixed models for repeated 
measures, only age adjusted results are presented in figures using mixed models for repeated 
measures. Different co-variance structures were explored, and the results are presented using 
heterogeneous Toeplitz. Dunnett’s method was used for multiple comparisons.  
Measurements of 17 -estradiol at the start and the finish of the cycles had higher 
coefficients of variation and higher rates of missing data as a result of variation in cycle 
length; therefore we included 17 -estradiol measurements from cycle day  10 to +9 in the 
linear mixed models. Results were considered statistically significant when the two-sided p 
value was < 0.05. 
 
Ethical considerations 
All the participating women signed an informed consent form. The study protocol was 
reviewed and approved by the Regional Committee for Medical Research Ethics North-
Norway and the Norwegian Data Inspectorate.  
 
Results 
The 204 participating women had mean age 30.7 years, mean birth weight 3389 g and self-
reported mean age at menarche 13.1 years. Mean BMI was 24.4 kg/m
2, mean waist 
circumference 79.5 cm and mean total fat percentage 34.1%. When dividing the women into 
tertiles of birth weight (< 3220 g,   3220 to 3530 g and   3530 g), women in the highest 
tertile of birth weight had the lowest overall average salivary and thus free 17 -estradiol  21.01.2009   7 
concentrations (p = 0.03), and tended to have a later age at menarche (p = 0.06) (Table 1). In 
addition, women with the lowest birth weight had significantly higher serum insulin levels (p 
= 0.02) compared with women with higher birth weights. 
We also studied the average 17 -estradiol by cycle day over the entire menstrual cycle 
across birth weight tertiles. Women who reported the highest birth weight (  3530 g) tended 
to have the lowest levels of daily free 17 -estradiol over the entire menstrual cycle (Figure 
1a).  
No clear pattern was observed between 17 -estradiol by cycle day over the entire menstrual 
cycle by tertiles of adult attained waist circumference (Figure 1b). 
We then studied the changes in overall average salivary 17 -estradiol concentration by 
1 standard deviation (SD) change in explanatory variables for each tertile of birth weight. 
Among women in the two lowest tertiles of birth weight (< 3530 g), we observed a pattern of 
positive association between measures of adult attained body composition and serum leptin 
and insulin levels and mean overall 17 -estradiol concentration in both age-adjusted models 
and models adjusted for potential confounders (smoking, physical activity and age at 
menarche). For each 3.8 kg/m
2 (1 SD) increase in BMI, the overall adjusted level of 17 -
estradiol in the lowest birth weight tertile increased by 2.74 pmol/L (95% CI, 0.63, 4.85), and 
in the middle birth weight tertile by 2.84 pmol/L (95% CI, 0.56, 5.11), equivalent to a 15.3% 
change in mean average concentration of 17 -estradiol in the lowest birth weight tertile and a 
15.9% change in the middle birth weight tertile, respectively. In contrast, among women in 
the highest tertile of birth weight (  3530 g), the level of 17 -estradiol did not vary with 
changes in adult body composition and serum hormones (Table 2).  
When we examined changes in waist circumference by tertiles of birth weight, we 
observed that for each 9.8 cm (1 SD) increase in waist circumference, the overall adjusted 
level of 17 -estradiol in the lowest birth weight tertile tended to increase. Among women in 
the middle birth weight tertile each 1 SD increase in waist circumference was associated with 
an increase of 3.05 pmol/L (95% CI, 0.53,5.57) in overall average 17 -estradiol levels, which 
equals a 17.0% change in overall average 17 -estradiol concentration. The results were even 
more pronounced when we performed the analyses by birth weight in quartiles (data not 
shown). 
To study in detail whether age at menarche influenced our result, we performed 
analysis stratified by age at menarche. Among women with low birth weight (< 3220 g), the 
relationship between measures of excess adult waist circumference and overall 17 -estradiol  21.01.2009   8 
concentrations was strongest in the subgroup of those having an age at menarche < 12 years. 
For each 9.8 cm (1 SD) increase in waist, overall average 17 -estradiol concentration 
increased by 3.9 pmol/L, which equals a 21.8% change in mean overall 17 -estradiol levels 
among women in the lowest birth weight tertile (p = 0.03; not presented in tables). 
In our study we observed a significant relationship between birth weight and serum 
insulin levels. When we examined birth weight in relation to adult overweight, the results 
became even clearer. Women of low birth weight (< 3220 g) who later became overweight (as 
defined by a waist circumference   84 cm) had twice as high insulin levels (145.4 pmol/L) 
than women of low birth weight and adult waist circumference < 84 cm (77.7 pmol/l; p = 
0.0018; data not shown in tables). 
To study the differences in daily salivary 17 -estradiol concentrations over an entire 
menstrual cycle between subgroups of women characterized by birth weight and adult 
attained waist, we used a linear mixed model for repeated measures (Figures 2a-c). We 
observed that birth weight combined with adult waist circumference showed a clear 
association with levels of premenopausal 17 -estradiol throughout an entire menstrual cycle. 
Women with birth weights < 3530 g who later developed excess body weight (waist    84 cm) 
showed higher 17 -estradiol concentrations over the menstrual cycle compared with women 
of higher birth weights (  3530 g) and adult excess body weight (p = 0.03; Figure 2a). These 
results equal a change in mean overall concentration of 17 -estradiol for the total group of 33 
%. Comparable results were also observed among women with an early age at menarche 
compared to later age at menarche; among women of lower birth weight (< 3530 g) and adult 
excess waist, those with an early age at menarche (< 12 years) had higher levels of 17 -
estradiol over their menstrual cycle compared with those who had a later age at menarche (p = 
0.07; Figure 2b). Women with lower birth weights (< 3530 g), early age at menarche 
(< 12 years) and adult overweight also tended to have higher insulin levels than those who 
were older at menarche (  12 years), although the difference was not significant (data not 
presented). Among those in the lowest birth weight tertile (< 3220 g) who later had a larger 
waist circumference (  84 cm, highest quartile), there was a trend for those with early age at 
menarche (< 12 years) to have even higher levels of 17 -estradiol over a whole menstrual 
cycle compared with those with later age at menarche (p = 0.09; Figure 2c). 
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In our study of young healthy women with regular menstrual cycles we found that low birth 
weight  (< 3530 g) combined with large attained adult waist ( 84 cm) resulted in a 33% 
increase in free 17 -estradiol levels over an entire menstrual cycle compared with women of 
higher birth weight and the same adult waist circumference. This association was even more 
pronounced among women of even lower birth weights, < 3220 g, combined with early age at 
menarche (< 12 years). 
Little is known about the interrelationship of birth weight, adult attained body 
composition and 17 -estradiol levels over an entire menstrual cycle. Therefore, one could ask 
whether these results can be explained by plausible biological mechanisms, observations from 
other studies or by bias and/or confounding. Interestingly, several studies have observed that 
perinatal factors, including birth weight, may influence later susceptibility of chronic diseases 
including breast cancer (25), (26), (5), (27), (28). Moreover, the association related to breast 
cancer has been complicated by contradictory results (29), (30) because some have observed a 
protective effect of low birth weight (25), whereas others have not (31). We have previously 
hypothesized that birth size may influence later responsiveness of ovarian function and have 
shown that, among adult women ovarian response to physical activity depends on their size at 
birth (32). Women of low birth weights may have a different set point for their physiological 
responsiveness than women with higher birth weights. Barker has proposed that fetal tissues 
respond to the intrauterine environment by permanently altering their structure and function 
(2). Such a mechanism may explain associations between low birth weight and increased risk 
of chronic diseases (33), including breast cancer risk.  
Other studies have shown a clear interrelationship of low birth weight, later 
overweight and susceptibility of chronic diseases (34). One biological explanation of this 
could be that individuals
 programmed for poor early nutrient intake would be put
 at risk if 
their food intake was subsequently increased to a level
 inappropriate for their
 
programming(35).  
Lissner et al. (36) furthermore found that birth weight was inversely related to serum 
leptin levels in adulthood, and that leptin can stimulate mitogenic and angiogenic processes in 
peripheral organs. Data obtained in cell and animal models and analyses of human breast 
cancer biopsies suggest involvement in breast cancer etiology (37). In our study we observed 
that serum leptin levels tended to be lower among women in the highest tertile of birth 
weight, although this result was not significant (Table 1).  
There is a growing recognition that breast
 cancer may be promoted by 
hyperinsulinemia and insulin resistance, which
 may favour a metabolic
 environment  21.01.2009   10 
promoting tumor growth (38). Additionally, insulin resistance and elevated serum steroid 
levels often coexist because of insulin up-regulation of ovarian steroid secretion (39). Low 
birth weight, thinness at 2 years of age and an increase in BMI after the age of 2 have been 
observed to be associated with development of insulin resistance in later life (40), (41), (42) 
underlining the importance of birth size as a risk factor for insulin resistance and other 
chronic diseases. Our study supports these findings by showing a significant relationship (p = 
0.02) between tertiles of birth weight and serum insulin levels. The results became even 
clearer when we looked into birth weight in relation to being overweight as an adult. Women 
of low birth weight (< 3220 g) who later became overweight (with a waist circumference 
  84 cm) had significantly higher insulin levels, compared with those of low birth weight and 
adult waist circumference < 84 cm. It is suggested that metabolic markers of high breast 
cancer risk include higher serum concentrations of insulin and IGF1 and also excessive 
abdominal fat accumulation (43). 
Mechanisms during gestation, such as increasing growth factor exposure and 
availability of energy influencing birth weight, may also influence later responsiveness to 
other factors. However, effect modification throughout childhood and adult life may interact 
and, among others, levels of 17 -estradiol over a menstrual cycle may vary.  
Several biological mechanisms and observation form different studies support a 
relationship between birth weight, childhood and adult weight gain and 17 -estradiol. Some 
studies have observed that childhood obesity may accelerate age at menarche, especially in 
those of low birth weight (5),(13),(44),(45), and early age at menarche is a known risk factor 
for breast cancer development. In our study we observed that women of birth weight < 3530 g 
tended to have an earlier age at menarche than those in the highest birth weight tertile, 
  3530 g. A Swedish study suggested that girls who at birth were relatively small for 
gestational age had higher childhood growth velocities than other girls (46). These results 
indicate that there may be compensation for those with fetal growth restriction through higher 
growth rate after birth. It is also possible that such compensatory growth could be mediated 
by increased levels of adrenal steroids and hyperinsulinemia in girls who were relatively 
small at birth (47), (40). Our observation that women with low birth weight and adult obesity 
tend to have higher levels of both insulin and 17 -estradiol over a menstrual cycle supports 
these findings. On the other hand, higher birth weight together with low pre-pubertal body 
weight have been observed to result in later age at menarche and lower estradiol 
concentrations (48).   21.01.2009   11 
Ovarian steroids are thought to increase the rate of breast cancer growth mainly by 
stimulating the mitotic activity of breast epithelial cells both directly and through interaction 
with growth hormones (49). One implication of the accumulating evidence on the importance 
of ovulatory menstrual cycles is that any factor that modifies menstrual cycle patterns and 
reduces the frequency of ovulation may reduce a woman’s lifetime risk of developing breast 
cancer (50). Consequently, reducing lifetime estrogen levels might be the most important step 
in lowering breast cancer in women.  
The use of just one clinical research department at a university hospital with one 
specially trained nurse enhanced the quality of our data. It allowed us to sample all clinical 
variables within the same narrow frame of the cycle for each participant, using uniform 
procedures. To limit any potential influence of variation in daylight, women did not 
participate during those months with markedly less daylight (December and January). 
The present population consists of only 204 women which limit the possibility to 
perform subgroup analyses. Moreover, it also underlines the necessity to interpret our results 
with cautiousness and the need for further studies among other ethnic groups. However, the 
population is very homogenous which may strengthen the interpretation in smaller groups. 
Taking daily saliva samples allowed estimation of daily estradiol concentrations over one 
menstrual cycle, enabling precise and reliable assessment of interindividual variations in 
hormonal levels. We used well-developed and validated methods and assays to characterize 
the women’s exposure to free, biologically active, ovarian steroids and the comparison of 
levels by aligned cycle days (24). This study had the benefit of collecting samples every day 
over an entire menstrual cycle, rather than only on selected days within a cycle (51). In 
addition, salivary levels of estradiol were shown to be quite stable within participants over 
time (52). 
  Age at menarche was recalled retrospectively, and misclassification is therefore 
likely. Several studies, however, have found that age at menarche are recalled with high 
reliability (53). In multivariate and stratified analyses we adjusted for potential confounders 
as age, smoking, physical activity and age at menarche. They were included in the final model 
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Our main findings support that lower birth weight, combined with large waist circumference 
during adulthood, is associated with increased levels of 17 -estradiol over one menstrual 
cycle, especially among women with early age at menarche (< 12 years). These women also 
had higher levels of insulin. This supports the hypothesis that women of lower birth weight 
may have a different set point for their physiological responsiveness than women of higher 
birth weight; this may, in turn, influence levels of reproductive hormones such as 17 -
estradiol. Our findings support the hypothesis that conditions during fetal, childhood and adult 
life may in combination influence later breast cancer risk.  
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 Table 1 Characteristics of the study population in tertiles of birth weight, means (SD)*: The 










































*SD, standard deviation. 
a Numbers of participants may vary as a result of missing information for certain variables.  
b One-way analysis of variance or  
2 test. 
c Blood sampling first visit (days 1–5). 










     < 3220 g  
     (n = 68) 
  3220–3530 g 
    (n = 68) 
  3530 g  





Age (years)  30.8 (3.2)  30.8 (2.9)  30.6 (3.2)  0.71 
Years of schooling  15.7 (3.2)  16.2 (2.8)  16.3 (3.1)  0.22 
Ethnic minority, Sami (%)  10.3  7.4  5.9  0.62 
Anthropometric measurements         
  BMI (kg/m
2)  23.9 (3.6)  25.5 (4.1)  23.9 (3.4)  0.96 
  Waist circumference (cm)  78.2 (10.3)  81.4 (9.9)  79.0 (9.1)  0.60 
  Total fat (%)  33.8 (8.3)  36.1 (7.1)  32.5 (7.1)  0.35 
Saliva hormone concentrations (pmol/L)         
  Overall 17 -estradiol  18.8 (8.3)  19.5 (10.2)  15.5 (7.3)  0.03 
Serum hormone concentrations
c          
  Serum estradiol (nmol/L)  0.14 (0.1)  0.15 (0.1)  0.15 (0.1)  0.50 
  Serum leptin (pmol/L)  826.8 (561.7)  968.8 (571.7)  772.8 (544.9)  0.58 
  Serum glucose (mmol/L)  5.0 (0.6)  5.1 (0.5)  5.0 (0.6)  0.59 
  Serum insulin (pmol/L)  95.6 (80.8)  90.1 (53.0)  71.5 (30.9)  0.02 
Menstrual and reproductive characteristics         
  Menarche (years)  12.96 (1.3)  12.98 (1.3)  13.40 (1.5)  0.06 
  Age at first birth (years)
d  23.0 (4.2)  25.7 (3.8)  24.6 (3.2)  0.10 
  Percentage women with children  45.6  50.0  48.5  0.73 
  Cycle length (days)  28.3 (3.0)  28.7 (3.3)  27.8 (3.1)  0.36 
Previous use of hormonal contraceptives (%)   
80.9  88.1  82.4 
 
0.82 
Energy intake (kJ/day)  7968  (1452)  7976 (2093)  8335 (2088)  0.26 
Leisure time (MET h/week)  51.8 (36.8)  51.8 (33.6)  53.7 (38.2)  0.76 
Alcohol units per week among users (n=190 )  2.8 (3.4)  3.3 (3.6)  3.2 (3.2)  0.47 
Current smokers (%)  20.6  14.7  30.9  0.15 Table 2 Estimated changes
* in mean salivary 17 -estradiol concentrations (pmol/L) with 95% CI by 1 standard deviation (SD) increase in 
explanatory variable by tertiles of birth weight (n = 204)
a 
 
                                                        
                                                      Change in 17 -estradiol levels (pmol/L) 
Variable  Mean   (SD)   
 
                      < 3220 g  
                      (n = 68) 
 
           Birth weight  
 
            3220 g , < 3530 g  
                    (n = 68) 
 
 
                         3530 g  











    Age adjusted          Adjusted
b 
 
  2.33 (0.23, 4.42)          2.74 (0.63, 4.85) 
    Age adjusted           Adjusted
b 
 
 2.97 (0.82, 5.12)            2.84  (0.56, 5.11) 
   Age adjusted                  Adjusted
b 
 








  1.17 ( 0.79, 3.13)        1.67 (-0.31, 3.66)  
 
 3.20 (0.85, 5.55)            3.05  (0.53, 5.57) 
 
  0.16  ( 2.08, 1.76)             -0.28  (-2.12, 1.55) 
 








  1.02 ( 0.85, 2.90)        1.69 (-0.26, 3.64) 
 
 
 2.41 ( 0.22, 5.03)          2.25  (-0.50, 5.01) 
 
   0.24  ( 1.68, 2.15)             -0.09  (-2.01, 1.83) 
Leptin (pmol/L)  856.1  (562.9)    1.93 ( 0.08, 3.94)        2.93 (0.87, 4.98)   1.43 ( 1.00, 3.85)          1.24  (-1.27, 3.75)    0.26  ( 2.1, 1.57)               -0.12  (-1.88, 1.64) 
Insulin (pmol/L)     85.7  (59.2)    0.07 ( 1.44, 1.57)         0.15 (-1.42, 1.73)   3.60 (0.96, 6.24)             3.75  (1.00, 6.50)    0.56  ( 3,95, 2,83)             -0.22  (-3.54, 3.09) 
           
 
*Linear regression analyses. Regression coefficient and 95% confidence interval (CI). 
aNumber may vary as a result of missing serum values.  
bAdjusted for age, leisure time physical activity, number of cigarettes and age at menarche.  






 Figure 1 
a) Average 17 -estradiol by cycle day over the entire menstrual cycle across tertiles of birth 
weight (BW), (< 3220g,  3220g and <3530g,  3530g). 
 
b) Average 17 -estradiol by cycle day over the entire menstrual cycle by tertiles of adult 
attained waist circumference (Waist), (<74 cm,  74 and < 82 cm,  82 cm). 
 
Figure 2  
a) Age-adjusted salivary 17 -estradiol concentrations by cycle day in women categorized by 
anthropometric measurements, highest compared with lower birth weight (BW) tertiles 
combined with being overweight in adulthood (waist  84cm). 
 
b) Age-adjusted salivary 17 -estradiol concentrations by cycle day in women categorized by 
birth weight (BW) < 3530 g, adult obesity (waist  84cm) and age at menarche. 
 
c) Age-adjusted salivary 17 -estradiol concentrations by cycle day in women categorized by 
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BW<3220 and waist 84cm and
menarche<12yrs,n=4
BW<3220 and waist 84cm and
menarche 12yrs,n=14
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c  